These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 34644216)

  • 61. Identification of Transcription Factor-Related Gene Signature and Risk Score Model for Colon Adenocarcinoma.
    Lin J; Cao Z; Yu D; Cai W
    Front Genet; 2021; 12():709133. PubMed ID: 34603375
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A Novel Cancer Stemness-Related Signature for Predicting Prognosis in Patients with Colon Adenocarcinoma.
    Wang W; Xu C; Ren Y; Wang S; Liao C; Fu X; Hu H
    Stem Cells Int; 2021; 2021():7036059. PubMed ID: 34691191
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
    Yue C; Ma H; Zhou Y
    PeerJ; 2019; 7():e8128. PubMed ID: 31803536
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Construction of a Prognostic Model Based on Methylation-Related Genes in Patients with Colon Adenocarcinoma.
    Liu Z; Xu Y; Jin S; Liu X; Wang B
    Cancer Manag Res; 2023; 15():1097-1110. PubMed ID: 37818334
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Identification of DLL3-related genes affecting the prognosis of patients with colon adenocarcinoma.
    Xiang J; Gong W; Liu J; Zhang H; Li M; Wang R; Lv Y; Sun P
    Front Genet; 2023; 14():1098190. PubMed ID: 37274780
    [No Abstract]   [Full Text] [Related]  

  • 66. High expression of PI4K2A predicted poor prognosis of colon adenocarcinoma (COAD) and correlated with immunity.
    Huang X; Cao Y; Bao P; Zhu B; Cheng Z
    Cancer Med; 2023 Jan; 12(1):837-851. PubMed ID: 35634680
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A novel machine learning model based on ubiquitin-related gene pairs and clinical features to predict prognosis and treatment effect in colon adenocarcinoma.
    Liang L; Liu L; Mai S; Chen Y
    Eur J Med Res; 2023 Jan; 28(1):41. PubMed ID: 36681855
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A novel defined cuproptosis-related gene signature for predicting the prognosis of colon adenocarcinoma.
    Luo B; Lin J; Ni A; Cai W; Yu X; Wang M
    Front Oncol; 2022; 12():927028. PubMed ID: 36505872
    [TBL] [Abstract][Full Text] [Related]  

  • 69. LncRNA ALMS1-IT1 is a novel prognostic biomarker and correlated with immune infiltrates in colon adenocarcinoma.
    Lin Y; Li Y; Chen Y; Zhang Z
    Medicine (Baltimore); 2022 Oct; 101(42):e31314. PubMed ID: 36281164
    [TBL] [Abstract][Full Text] [Related]  

  • 70. An integrated bioinformatic investigation of mitochondrial energy metabolism genes in colon adenocarcinoma followed by preliminary validation of CPT2 in tumor immune infiltration.
    Cao Z; Lin J; Fu G; Niu L; Yang Z; Cai W
    Front Immunol; 2022; 13():959967. PubMed ID: 36177002
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A glycolysis-related gene signature predicts prognosis of patients with esophageal adenocarcinoma.
    Kang H; Wang N; Wang X; Zhang Y; Lin S; Mao G; Liu D; Dang C; Zhou Z
    Aging (Albany NY); 2020 Nov; 12(24):25828-25844. PubMed ID: 33234735
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Study on the Expression Profile of Autophagy-Related Genes in Colon Adenocarcinoma.
    Hou M; Ma J; Ma J
    Comput Math Methods Med; 2022; 2022():7525048. PubMed ID: 35572821
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gene Expression Profiling of Tricarboxylic Acid Cycle and One Carbon Metabolism Related Genes for Prognostic Risk Signature of Colon Carcinoma.
    Zhang Z; Zhu H; Li Q; Gao W; Zang D; Su W; Yang R; Zhong J
    Front Genet; 2021; 12():647152. PubMed ID: 34589110
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Integrative Proteo-Genomic Analysis for Recurrent Survival Prognosis in Colon Adenocarcinoma.
    Ai F; Wang W; Liu S; Zhang D; Yang Z; Liu F
    Front Oncol; 2022; 12():871568. PubMed ID: 35847888
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Establishing and Validating an Aging-Related Prognostic Four-Gene Signature in Colon Adenocarcinoma.
    Zheng L; Yang Y; Cui X
    Biomed Res Int; 2021; 2021():4682589. PubMed ID: 34790819
    [TBL] [Abstract][Full Text] [Related]  

  • 76. GPC1 Is Associated with Poor Prognosis and Treg Infiltration in Colon Adenocarcinoma.
    Liu Y; Ren H; Yang MQ; Li JY
    Comput Math Methods Med; 2022; 2022():8209700. PubMed ID: 36158119
    [TBL] [Abstract][Full Text] [Related]  

  • 77. PANoptosis-related genes function as efficient prognostic biomarkers in colon adenocarcinoma.
    Liu Y; Wang Y; Feng H; Ma L; Liu Y
    Front Endocrinol (Lausanne); 2024; 15():1344058. PubMed ID: 38501104
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Investigation and verification of the clinical significance and perspective of natural killer group 2 member D ligands in colon adenocarcinoma.
    Ruan GT; Wang S; Zhu LC; Liao XW; Wang XK; Liao C; Yan L; Xie HL; Gong YZ; Gan JL; Gao F
    Aging (Albany NY); 2021 Apr; 13(9):12565-12586. PubMed ID: 33909599
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hypoxia-Related Gene-Based Signature Can Evaluate the Tumor Immune Microenvironment and Predict the Prognosis of Colon Adenocarcinoma Patients.
    He X; Ding J; Cheng X; Xiong M
    Int J Gen Med; 2021; 14():9853-9862. PubMed ID: 34938106
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Metabolism-Related Prognostic Biomarkers, Purine Metabolism and Anti-Tumor Immunity in Colon Adenocarcinoma.
    Liu H; Zhang Y; Zhang Q; Zhang T; Lu T
    Front Biosci (Landmark Ed); 2023 Dec; 28(12):328. PubMed ID: 38179743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.